New scan seeks to spot lung damage earlier
NCT ID NCT05914506
Summary
This study is testing whether a new type of MRI scan, using a special inhaled gas called hyperpolarized xenon, can better detect and monitor lung scarring (fibrosis) and related heart effects in people with progressive fibrosing lung disease. It aims to see if this scan is more sensitive than current tests at spotting early changes and tracking how the disease progresses or responds to treatment. The study involves 30 participants who are already prescribed anti-fibrotic drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus University, Department of Clinical Medicine, MR Research Centre
Aarhus, 8200, Denmark
Conditions
Explore the condition pages connected to this study.